ArticleAmerican journal of cancer research2024

HER2-targeted ADC DX126-262 combined with chemotherapy demonstrates superior antitumor efficacy in HER2-positive gastric cancer.

Xiaobo Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.